Home Cart Sign in  
Chemical Structure| 303175-44-2 Chemical Structure| 303175-44-2

Structure of Zapnometinib
CAS No.: 303175-44-2

Chemical Structure| 303175-44-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Zapnometinib is a MEK inhibitor, with an IC50 of 5.7 nM.

Synonyms: PD0184264; ATR-002

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Zapnometinib

CAS No. :303175-44-2
Formula : C13H7ClF2INO2
M.W : 409.55
SMILES Code : O=C(O)C1=CC=C(F)C(F)=C1NC2=CC=C(I)C=C2Cl
Synonyms :
PD0184264; ATR-002
MDL No. :MFCD09840238
InChI Key :XCNBGWKQXRQKSA-UHFFFAOYSA-N
Pubchem ID :10112191

Safety of Zapnometinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H413
Precautionary Statements:P264-P270-P273-P301+P312+P330-P501

Related Pathways of Zapnometinib

MAPK

Isoform Comparison

Biological Activity

Description
Zapnometinib (PD0184264), a MEK inhibitor and active metabolite of CI-1040, displays an IC50 of 5.7 nM. It demonstrates antiviral activity against influenza virus and antibacterial effects [1][2][3].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.44mL

0.49mL

0.24mL

12.21mL

2.44mL

1.22mL

24.42mL

4.88mL

2.44mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories